March 14, 2017 09:02 PM EDTUpdated 11:48 AM
Pharma

FDA OKs Mer­ck’s Keytru­da for Hodgkin lym­phoma, a first in blood can­cer

Arsalan Arif

Founder

Mer­ck has racked up an­oth­er FDA ap­proval for Keytru­da, this time for clas­si­cal Hodgkin lym­phoma, mark­ing the PD-1 block­er’s first …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times